Low-dose oral nicotinamide mononucleotide for immune thrombocytopenia: a phase 1/2 trial. (nature.com)

Authors: Li H … Zhang L Journal: Nature Medicine Published: 2026-06-01 DOI: https://doi.org/10.1038/s41591-026-04366-x